Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle

Seema Mital, Wendy K. Chung, Steven D. Colan, Lynn A. Sleeper, Cedric Manlhiot, Cammon B. Arrington, James F. Cnota, Eric M. Graham, Michael E. Mitchell, Elizabeth Goldmuntz, Jennifer S. Li, Jami C. Levine, Teresa M. Lee, Renee Margossian, Daphne T. Hsu

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background-: We investigated the effect of polymorphisms in the renin-angiotensin-aldosterone system (RAAS) genes on ventricular remodeling, growth, renal function, and response to enalapril in infants with single ventricle. Methods and results-: Single ventricle infants enrolled in a randomized trial of enalapril were genotyped for polymorphisms in 5 genes: angiotensinogen, angiotensin-converting enzyme, angiotensin II type 1 receptor, aldosterone synthase, and chymase. Alleles associated with renin-angiotensin- aldosterone system upregulation were classified as risk alleles. Ventricular mass, volume, somatic growth, renal function using estimated glomerular filtration rate, and response to enalapril were compared between patients with 2 homozygous risk genotypes (high risk), and those with <2 homozygous risk genotypes (low risk) at 2 time points: before the superior cavopulmonary connection (pre-SCPC) and at age 14 months. Of 230 trial subjects, 154 were genotyped: Thirty-eight were high risk, and 116 were low risk. Ventricular mass and volume were elevated in both groups pre-SCPC. Ventricular mass and volume decreased and estimated glomerular filtration rate increased after SCPC in the low-risk (P<0.05), but not the high-risk group. These responses were independent of enalapril treatment. Weight and height z-scores were lower at baseline, and height remained lower in the high-risk group at 14 months, especially in those receiving enalapril (P<0.05). Conclusions-: Renin-angiotensin-aldosterone system-upregulation genotypes were associated with failure of reverse remodeling after SCPC surgery, less improvement in renal function, and impaired somatic growth, the latter especially in patients receiving enalapril. Renin-angiotensin-aldosterone system genotype may identify a high-risk subgroup of single ventricle patients who fail to fully benefit from volume-unloading surgery. Follow-up is warranted to assess long-term impact.

Original languageEnglish (US)
Pages (from-to)2353-2362
Number of pages10
JournalCirculation
Volume123
Issue number21
DOIs
StatePublished - May 31 2011
Externally publishedYes

Fingerprint

Ventricular Remodeling
Angiotensins
Aldosterone
Renin
Genotype
Enalapril
Renin-Angiotensin System
Glomerular Filtration Rate
Kidney
Up-Regulation
Growth
Alleles
Cytochrome P-450 CYP11B2
Chymases
Angiotensinogen
Angiotensin Type 1 Receptor
Peptidyl-Dipeptidase A
Genes

Keywords

  • angiotensin-converting enzyme inhibitors
  • congenital heart disease
  • genetic association analysis
  • heart surgery
  • hypertrophy

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. / Mital, Seema; Chung, Wendy K.; Colan, Steven D.; Sleeper, Lynn A.; Manlhiot, Cedric; Arrington, Cammon B.; Cnota, James F.; Graham, Eric M.; Mitchell, Michael E.; Goldmuntz, Elizabeth; Li, Jennifer S.; Levine, Jami C.; Lee, Teresa M.; Margossian, Renee; Hsu, Daphne T.

In: Circulation, Vol. 123, No. 21, 31.05.2011, p. 2353-2362.

Research output: Contribution to journalArticle

Mital, S, Chung, WK, Colan, SD, Sleeper, LA, Manlhiot, C, Arrington, CB, Cnota, JF, Graham, EM, Mitchell, ME, Goldmuntz, E, Li, JS, Levine, JC, Lee, TM, Margossian, R & Hsu, DT 2011, 'Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle', Circulation, vol. 123, no. 21, pp. 2353-2362. https://doi.org/10.1161/CIRCULATIONAHA.110.004341
Mital, Seema ; Chung, Wendy K. ; Colan, Steven D. ; Sleeper, Lynn A. ; Manlhiot, Cedric ; Arrington, Cammon B. ; Cnota, James F. ; Graham, Eric M. ; Mitchell, Michael E. ; Goldmuntz, Elizabeth ; Li, Jennifer S. ; Levine, Jami C. ; Lee, Teresa M. ; Margossian, Renee ; Hsu, Daphne T. / Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. In: Circulation. 2011 ; Vol. 123, No. 21. pp. 2353-2362.
@article{0de138806ec046a7b03fe36e5958b4be,
title = "Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle",
abstract = "Background-: We investigated the effect of polymorphisms in the renin-angiotensin-aldosterone system (RAAS) genes on ventricular remodeling, growth, renal function, and response to enalapril in infants with single ventricle. Methods and results-: Single ventricle infants enrolled in a randomized trial of enalapril were genotyped for polymorphisms in 5 genes: angiotensinogen, angiotensin-converting enzyme, angiotensin II type 1 receptor, aldosterone synthase, and chymase. Alleles associated with renin-angiotensin- aldosterone system upregulation were classified as risk alleles. Ventricular mass, volume, somatic growth, renal function using estimated glomerular filtration rate, and response to enalapril were compared between patients with 2 homozygous risk genotypes (high risk), and those with <2 homozygous risk genotypes (low risk) at 2 time points: before the superior cavopulmonary connection (pre-SCPC) and at age 14 months. Of 230 trial subjects, 154 were genotyped: Thirty-eight were high risk, and 116 were low risk. Ventricular mass and volume were elevated in both groups pre-SCPC. Ventricular mass and volume decreased and estimated glomerular filtration rate increased after SCPC in the low-risk (P<0.05), but not the high-risk group. These responses were independent of enalapril treatment. Weight and height z-scores were lower at baseline, and height remained lower in the high-risk group at 14 months, especially in those receiving enalapril (P<0.05). Conclusions-: Renin-angiotensin-aldosterone system-upregulation genotypes were associated with failure of reverse remodeling after SCPC surgery, less improvement in renal function, and impaired somatic growth, the latter especially in patients receiving enalapril. Renin-angiotensin-aldosterone system genotype may identify a high-risk subgroup of single ventricle patients who fail to fully benefit from volume-unloading surgery. Follow-up is warranted to assess long-term impact.",
keywords = "angiotensin-converting enzyme inhibitors, congenital heart disease, genetic association analysis, heart surgery, hypertrophy",
author = "Seema Mital and Chung, {Wendy K.} and Colan, {Steven D.} and Sleeper, {Lynn A.} and Cedric Manlhiot and Arrington, {Cammon B.} and Cnota, {James F.} and Graham, {Eric M.} and Mitchell, {Michael E.} and Elizabeth Goldmuntz and Li, {Jennifer S.} and Levine, {Jami C.} and Lee, {Teresa M.} and Renee Margossian and Hsu, {Daphne T.}",
year = "2011",
month = "5",
day = "31",
doi = "10.1161/CIRCULATIONAHA.110.004341",
language = "English (US)",
volume = "123",
pages = "2353--2362",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "21",

}

TY - JOUR

T1 - Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle

AU - Mital, Seema

AU - Chung, Wendy K.

AU - Colan, Steven D.

AU - Sleeper, Lynn A.

AU - Manlhiot, Cedric

AU - Arrington, Cammon B.

AU - Cnota, James F.

AU - Graham, Eric M.

AU - Mitchell, Michael E.

AU - Goldmuntz, Elizabeth

AU - Li, Jennifer S.

AU - Levine, Jami C.

AU - Lee, Teresa M.

AU - Margossian, Renee

AU - Hsu, Daphne T.

PY - 2011/5/31

Y1 - 2011/5/31

N2 - Background-: We investigated the effect of polymorphisms in the renin-angiotensin-aldosterone system (RAAS) genes on ventricular remodeling, growth, renal function, and response to enalapril in infants with single ventricle. Methods and results-: Single ventricle infants enrolled in a randomized trial of enalapril were genotyped for polymorphisms in 5 genes: angiotensinogen, angiotensin-converting enzyme, angiotensin II type 1 receptor, aldosterone synthase, and chymase. Alleles associated with renin-angiotensin- aldosterone system upregulation were classified as risk alleles. Ventricular mass, volume, somatic growth, renal function using estimated glomerular filtration rate, and response to enalapril were compared between patients with 2 homozygous risk genotypes (high risk), and those with <2 homozygous risk genotypes (low risk) at 2 time points: before the superior cavopulmonary connection (pre-SCPC) and at age 14 months. Of 230 trial subjects, 154 were genotyped: Thirty-eight were high risk, and 116 were low risk. Ventricular mass and volume were elevated in both groups pre-SCPC. Ventricular mass and volume decreased and estimated glomerular filtration rate increased after SCPC in the low-risk (P<0.05), but not the high-risk group. These responses were independent of enalapril treatment. Weight and height z-scores were lower at baseline, and height remained lower in the high-risk group at 14 months, especially in those receiving enalapril (P<0.05). Conclusions-: Renin-angiotensin-aldosterone system-upregulation genotypes were associated with failure of reverse remodeling after SCPC surgery, less improvement in renal function, and impaired somatic growth, the latter especially in patients receiving enalapril. Renin-angiotensin-aldosterone system genotype may identify a high-risk subgroup of single ventricle patients who fail to fully benefit from volume-unloading surgery. Follow-up is warranted to assess long-term impact.

AB - Background-: We investigated the effect of polymorphisms in the renin-angiotensin-aldosterone system (RAAS) genes on ventricular remodeling, growth, renal function, and response to enalapril in infants with single ventricle. Methods and results-: Single ventricle infants enrolled in a randomized trial of enalapril were genotyped for polymorphisms in 5 genes: angiotensinogen, angiotensin-converting enzyme, angiotensin II type 1 receptor, aldosterone synthase, and chymase. Alleles associated with renin-angiotensin- aldosterone system upregulation were classified as risk alleles. Ventricular mass, volume, somatic growth, renal function using estimated glomerular filtration rate, and response to enalapril were compared between patients with 2 homozygous risk genotypes (high risk), and those with <2 homozygous risk genotypes (low risk) at 2 time points: before the superior cavopulmonary connection (pre-SCPC) and at age 14 months. Of 230 trial subjects, 154 were genotyped: Thirty-eight were high risk, and 116 were low risk. Ventricular mass and volume were elevated in both groups pre-SCPC. Ventricular mass and volume decreased and estimated glomerular filtration rate increased after SCPC in the low-risk (P<0.05), but not the high-risk group. These responses were independent of enalapril treatment. Weight and height z-scores were lower at baseline, and height remained lower in the high-risk group at 14 months, especially in those receiving enalapril (P<0.05). Conclusions-: Renin-angiotensin-aldosterone system-upregulation genotypes were associated with failure of reverse remodeling after SCPC surgery, less improvement in renal function, and impaired somatic growth, the latter especially in patients receiving enalapril. Renin-angiotensin-aldosterone system genotype may identify a high-risk subgroup of single ventricle patients who fail to fully benefit from volume-unloading surgery. Follow-up is warranted to assess long-term impact.

KW - angiotensin-converting enzyme inhibitors

KW - congenital heart disease

KW - genetic association analysis

KW - heart surgery

KW - hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=79958100222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958100222&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.110.004341

DO - 10.1161/CIRCULATIONAHA.110.004341

M3 - Article

VL - 123

SP - 2353

EP - 2362

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 21

ER -